SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-050365
Filing Date
2024-06-06
Accepted
2024-06-06 16:05:42
Documents
13
Period of Report
2024-06-05
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0207441-8k_nektar.htm   iXBRL 8-K 34490
  Complete submission text file 0001213900-24-050365.txt   206360

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE nktr-20240605.xsd EX-101.SCH 3009
3 XBRL LABEL FILE nktr-20240605_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE nktr-20240605_pre.xml EX-101.PRE 22355
16 EXTRACTED XBRL INSTANCE DOCUMENT ea0207441-8k_nektar_htm.xml XML 3565
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24006 | Film No.: 241025027
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)